The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 30, 2019

Filed:

May. 12, 2017
Applicant:

Dana Farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

William G. Kaelin, Jr., Boston, MA (US);

Mircea Ivan, Indianapolis, IN (US);

Assignee:

Dana Farber Cancer Institute, Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/573 (2006.01); A61K 38/17 (2006.01); A61K 38/44 (2006.01); C12Q 1/26 (2006.01); A61K 31/00 (2006.01); A61K 31/70 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); A61K 31/00 (2013.01); A61K 31/70 (2013.01); A61K 38/1709 (2013.01); A61K 38/44 (2013.01); C12Q 1/26 (2013.01); C12Y 114/11002 (2013.01); G01N 2333/90245 (2013.01); G01N 2500/02 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract

Light-generating fusion proteins having a ligand binding site and a light-generating polypeptide moiety and their use as diagnostics, in drug screening and discovery, and as therapeutics, are disclosed. The light-generating fusion protein has a feature where the bioluminescence of the polypeptide moiety changes upon binding of a ligand at the ligand binding site. The ligand may be, for example, an enzyme present in an environment only under certain conditions, e.g., ubiquitin ligase in a hypoxic state, such that the light-generating fusion protein is 'turned on' only under such conditions.


Find Patent Forward Citations

Loading…